Skip to content
Screener

Viking Therapeutics VKTX Q3 2026 earnings

Reported October 28, 2026 · After market close

EPS-$1.55Miss by $0.49
EPS estimate-$1.06

Next report

Date not yet announced

FAQ

When did Viking Therapeutics report Q3 2026 earnings?
Viking Therapeutics (VKTX) reported Q3 2026 earnings on October 28, 2026 after market close.
What were Viking Therapeutics's Q3 2026 revenue and EPS?
Viking Therapeutics reported eps of $-1.55 for Q3 2026.
Did Viking Therapeutics beat estimates in Q3 2026?
EPS missed the consensus estimate of $-1.06 by $0.49.
How did Viking Therapeutics's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 91.4% from $-0.81.
Where can I find Viking Therapeutics's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-436145) and the 10-Q periodic report (0001193125-26-436432) directly on SEC EDGAR. The filing index links above go to sec.gov.